Literature DB >> 30070732

Prognostic Value of the ESPEN Consensus and Guidelines for Malnutrition: Prediction of Post-Discharge Clinical Outcomes in Older Inpatients.

Dolores Sánchez-Rodríguez1,2,3,4, Cédric Annweiler5,6, Natalia Ronquillo-Moreno1, Olga Vázquez-Ibar1,4, Ferran Escalada2,3,7, Xavier Duran8, Josep M Muniesa2,3,7, Ester Marco2,3,7,9.   

Abstract

INTRODUCTION: Our study aimed to determine whether malnutrition and nutrition-related conditions using the European Society for Clinical Nutrition and Metabolism (ESPEN) consensus were associated with functional status, institutionalization, readmissions, and mortality in older patients at 3-month follow-up.
METHODS: A cohort of 102 consecutive deconditioned patients was assessed at 3 months postdischarge from postacute geriatric care. Inclusion criteria were age ≥70 years, scores of Mini-Mental Status Examination ≥21/30, and being admitted for rehabilitation after an acute non-disabling disease. Malnutrition as defined by ESPEN consensus and nutrition-related conditions (such as frailty, sarcopenia, overweight/obesity, nutrient deficiency, and cachexia) was assessed, and related to postdischarge clinical outcomes at 3-month follow-up.
RESULTS: Of 95 included patients (84.5 ± 6.5 years; 63.2% women), 31 had unintentional weight loss and 19 fulfilled malnutrition criteria defined by the ESPEN consensus. Nutrition-related conditions were frequent: 94 patients had frailty, 44 sarcopenia, 58 overweight/obesity, and 59 nutrient deficiency. Sarcopenia reduced functional status at 3-month follow-up (median difference: -25.5; 95% confidence interval (CI) -46.4 - -4.3, P = 0.008). Institutionalization was related to unintentional weight loss in univariate analysis (odds ratio (OR) = 3.9; 95%CI 1.3 - 12.4, P = 0.018). Meeting the basic ESPEN definition of malnutrition was related to institutionalization in univariate (OR = 3.4; 95%CI 1.0 to 11.3, P = 0.042) but not multivariate analysis, and was not significantly associated with readmissions or mortality at 3-month follow-up.
CONCLUSIONS: Further research is needed on the potential value of the ESPEN consensus and guidelines for malnutrition to identify older patients at risk of worse functional status, institutionalization, readmissions, and mortality at 3-month follow-up postdischarge.
© 2018 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  aged; malnutrition; mortality; patient outcome assessment; patient readmission

Mesh:

Year:  2018        PMID: 30070732     DOI: 10.1002/ncp.10088

Source DB:  PubMed          Journal:  Nutr Clin Pract        ISSN: 0884-5336            Impact factor:   3.080


  5 in total

1.  Taking a step toward implementation of Global Leadership Initiative on Malnutrition (GLIM) criteria in geriatric rehabilitation.

Authors:  Dolores Sanchez-Rodriguez; Ester Marco; Delky Meza-Valderrama; Vanesa Dávalos-Yerovi; Esther Duarte
Journal:  Eur Geriatr Med       Date:  2020-06       Impact factor: 1.710

Review 2.  Sarcopenia, Malnutrition, and Cachexia: Adapting Definitions and Terminology of Nutritional Disorders in Older People with Cancer.

Authors:  Delky Meza-Valderrama; Ester Marco; Vanesa Dávalos-Yerovi; Maria Dolors Muns; Marta Tejero-Sánchez; Esther Duarte; Dolores Sánchez-Rodríguez
Journal:  Nutrients       Date:  2021-02-26       Impact factor: 5.717

3.  Identifying older adults with frailty approaching end-of-life: A systematic review.

Authors:  Alex Hall; Elisabeth Boulton; Patience Kunonga; Gemma Spiers; Fiona Beyer; Peter Bower; Dawn Craig; Chris Todd; Barbara Hanratty
Journal:  Palliat Med       Date:  2021-09-14       Impact factor: 4.762

4.  Malnutrition as a Strong Predictor of the Onset of Sarcopenia.

Authors:  Charlotte Beaudart; Dolores Sanchez-Rodriguez; Médéa Locquet; Jean-Yves Reginster; Laetitia Lengelé; Olivier Bruyère
Journal:  Nutrients       Date:  2019-11-27       Impact factor: 5.717

5.  Mortality in malnourished older adults diagnosed by ESPEN and GLIM criteria in the SarcoPhAge study.

Authors:  Dolores Sanchez-Rodriguez; Médéa Locquet; Jean-Yves Reginster; Etienne Cavalier; Olivier Bruyère; Charlotte Beaudart
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-07-13       Impact factor: 12.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.